Deficiency of the immunostimulatory cytokine IL-21 promotes intestinal neoplasia via dysregulation of the Th1/Th17 axis

References

• Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH, Pages F et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 2011; 71:1263-71; PMID:21303976; http://dx.doi.org/10.1158/0008-5472.CAN-10-2907
   PubMed Web of Science ®Google Scholar
• Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, Gross JA, Johnston J, Madden K, Xu W, West J et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000; 408:57-63; PMID:11081504; http://dx.doi.org/10.1038/35040504
   PubMed Web of Science ®Google Scholar
• Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci U S A 2000; 97:11439-44; PMID:11016959; http://dx.doi.org/10.1073/pnas.200360997
   PubMed Web of Science ®Google Scholar
• Hsieh CL, Hsu SC, Shen CR, Chen MY, Liu SJ, Chong P, Chen HW. Increased expression of IL-21 reduces tumor growth by modulating the status of tumor-infiltrated lymphocytes. Immunobiology 2011; 216:491-6; PMID:20884078; http://dx.doi.org/10.1016/j.imbio.2010.09.002
   PubMed Web of Science ®Google Scholar
• Allard EL, Hardy MP, Leignadier J, Marquis M, Rooney J, Lehoux D, Labrecque N. Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation. Eur J Immunol 2007; 37:3069-77; PMID:17918202; http://dx.doi.org/10.1002/eji.200637017
   PubMed Web of Science ®Google Scholar
• Santegoets SJ, Turksma AW, Suhoski MM, Stam AG, Albelda SM, Hooijberg E, Scheper RJ, van den Eertwegh AJ, Gerritsen WR, Powell DJ, Jr. et al. IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells. J Transl Med 2013; 11:37; PMID:23402380; http://dx.doi.org/10.1186/1479-5876-11-37
   PubMed Web of Science ®Google Scholar
• Attridge K, Wang CJ, Wardzinski L, Kenefeck R, Chamberlain JL, Manzotti C, Kopf M, Walker LS. IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis. Blood 2012; 119:4656-64; PMID:22442347; http://dx.doi.org/10.1182/blood-2011-10-388546
   PubMed Web of Science ®Google Scholar
• Yu J, He S, Liu P, Hu Y, Wang L, Wang X, Han Y, Zhu X. Interleukin21 promotes the development of ulcerative colitis and regulates the proliferation and secretion of follicular T helper cells in the colitides microenvironment. Mol Med Rep 2015; 11:1049-56; PMID:25371082; http://dx.doi.org/10.3892/mmr.2014.2824
   PubMed Web of Science ®Google Scholar
• Fina D, Sarra M, Fantini MC, Rizzo A, Caruso R, Caprioli F, Stolfi C, Cardolini I, Dottori M, Boirivant M et al. Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology 2008; 134:1038-48; PMID:18395085; http://dx.doi.org/10.1053/j.gastro.2008.01.041
   PubMed Web of Science ®Google Scholar
• Jauch D, Martin M, Schiechl G, Kesselring R, Schlitt HJ, Geissler EK, Fichtner-Feigl S. Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice. Gut 2011; 60:1678-86; PMID:21948944; http://dx.doi.org/10.1136/gutjnl-2011-300612
   PubMed Web of Science ®Google Scholar
• Stolfi C, Rizzo A, Franze E, Rotondi A, Fantini MC, Sarra M, Caruso R, Monteleone I, Sileri P, Franceschilli L et al. Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J Exp Med 2011; 208:2279-90; PMID:21987656; http://dx.doi.org/10.1084/jem.20111106
   PubMed Web of Science ®Google Scholar
• Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010; 138:2101-14 e5; PMID:20420949; http://dx.doi.org/10.1053/j.gastro.2010.01.058
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung KE et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012; 491:254-8; PMID:23034650; http://dx.doi.org/10.1038/nature11465
   PubMed Web of Science ®Google Scholar
• Nandi B, Pai C, Huang Q, Prabhala RH, Munshi NC, Gold JS. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis. PLoS One 2014; 9:e97566; PMID:24866282; http://dx.doi.org/10.1371/journal.pone.0097566
   PubMedGoogle Scholar
• Gonzalez G, Huang Q, Mashimo H. Characterization of oncocytes in deep esophageal glands. Dis Esophagus 2016; 29:670-80; PMID:26245938; http://dx.doi.org/10.1111/dote.12382
   PubMed Web of Science ®Google Scholar
• Shapiro M, Nandi B, Pai C, Samur MK, Pelluru D, Fulciniti M, Prabhala RH, Munshi NC, Gold JS. Deficiency of IL-17A, but not the prototypical Th17 transcription factor RORgammat, decreases murine spontaneous intestinal tumorigenesis. Cancer Immunol Immunother 2016; 65:13-24; PMID:26559812; http://dx.doi.org/10.1007/s00262-015-1769-2
   PubMed Web of Science ®Google Scholar
• Ugai S, Shimozato O, Kawamura K, Wang YQ, Yamaguchi T, Saisho H, Sakiyama S, Tagawa M. Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts. Cancer Gene Ther 2003; 10:187-92; PMID:12637939; http://dx.doi.org/10.1038/sj.cgt.7700552
   PubMed Web of Science ®Google Scholar
• De Simone V, Ronchetti G, Franze E, Colantoni A, Ortenzi A, Fantini MC, Rizzo A, Sica GS, Sileri P, Rossi P et al. Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis. Oncotarget 2015; 6:9908-23; PMID:25839161; http://dx.doi.org/10.18632/oncotarget.3532
   PubMed Web of Science ®Google Scholar
• Venning FA CM, Kissow H. The Carcinogenic Agent Azoxymethane (AOM) enhances early inflammation-induced colon crypt pathology. J Cancer Sci Therapy 2013; 5:377-83; http://dx.doi.org/10.4172/1948-5956.1000229
   Google Scholar
• Sutherland AP, Joller N, Michaud M, Liu SM, Kuchroo VK, Grusby MJ. IL-21 promotes CD8+ CTL activity via the transcription factor T-bet. J Immunol 2013; 190:3977-84; PMID:23479229; http://dx.doi.org/10.4049/jimmunol.1201730
   PubMed Web of Science ®Google Scholar
• Chae WJ, Gibson TF, Zelterman D, Hao L, Henegariu O, Bothwell AL. Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci U S A 2010; 107:5540-4; PMID:20212110; http://dx.doi.org/10.1073/pnas.0912675107
   PubMed Web of Science ®Google Scholar
• Diederichsen AC, Hjelmborg J, Christensen PB, Zeuthen J, Fenger C. Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother 2003; 52:423-8; PMID:12695859; http://dx.doi.org/10.1007/s00262-003-0388-5
   PubMed Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 2013; 39:782-95; PMID:24138885; http://dx.doi.org/10.1016/j.immuni.2013.10.003
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Gao W, Awasthi A, Jager A, Strom TB, Oukka M, Kuchroo VK. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007; 448:484-7; PMID:17581588; http://dx.doi.org/10.1038/nature05970
   PubMed Web of Science ®Google Scholar
• Fantini MC, Rizzo A, Fina D, Caruso R, Becker C, Neurath MF, Macdonald TT, Pallone F, Monteleone G. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. Eur J Immunol 2007; 37:3155-63; PMID:17918200; http://dx.doi.org/10.1002/eji.200737766
   PubMed Web of Science ®Google Scholar
• Kastirr I, Maglie S, Paroni M, Alfen JS, Nizzoli G, Sugliano E, Crosti MC, Moro M, Steckel B, Steinfelder S et al. IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells. J Immunol 2014; 193:3322-31; PMID:25172491; http://dx.doi.org/10.4049/jimmunol.1400775
   PubMed Web of Science ®Google Scholar
• Wei L, Laurence A, Elias KM, O'Shea JJ. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 2007; 282:34605-10; PMID:17884812; http://dx.doi.org/10.1074/jbc.M705100200
   PubMed Web of Science ®Google Scholar
• Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8:967-74; PMID:17581537; http://dx.doi.org/10.1038/ni1488
   PubMed Web of Science ®Google Scholar
• Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, Schluns K, Tian Q, Watowich SS, Jetten AM et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007; 448:480-3; PMID:17581589; http://dx.doi.org/10.1038/nature05969
   PubMed Web of Science ®Google Scholar
• Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008; 454:350-2; PMID:18469800; http://dx.doi.org/10.1038/nature07021
   PubMed Web of Science ®Google Scholar
• Sonderegger I, Kisielow J, Meier R, King C, Kopf M. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur J Immunol 2008; 38:1833-8; PMID:18546146; http://dx.doi.org/10.1002/eji.200838511
   PubMed Web of Science ®Google Scholar
• Coquet JM, Chakravarti S, Smyth MJ, Godfrey DI. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J Immunol 2008; 180:7097-101; PMID:18490706; http://dx.doi.org/10.4049/jimmunol.180.11.7097
   PubMed Web of Science ®Google Scholar
• Lee Y, Mitsdoerffer M, Xiao S, Gu G, Sobel RA, Kuchroo VK. IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis. J Clin Invest 2015; 125:4011-20; PMID:26413871; http://dx.doi.org/10.1172/JCI75933
   PubMed Web of Science ®Google Scholar
• Tian Y, Zajac AJ. IL-21 and T Cell Differentiation: Consider the Context. Trends Immunol 2016; 37:557-68; PMID:27389961; http://dx.doi.org/10.1016/j.it.2016.06.001
   PubMed Web of Science ®Google Scholar